BlackRock · Health Care Sector
Blackrock Health Sciences Opportunities Portfolio: share classes compared
Blackrock Health Sciences Opportunities Portfolio has 6 share classes (4 with public tickers). They hold the same portfolio — $5.9 billion in total — but charge different fees and loads. The cheapest is SHSSX (Institutional) at 0.86%.
| Ticker | Share class | Type | Expense ratio | Front load | 12b-1 | 1-yr | 5-yr | 10-yr |
|---|---|---|---|---|---|---|---|---|
| SHSSX | Institutional | Mutual fund | 0.86% | 0% | 0% | +16.3% | +5.9% | +9.8% |
| SHSAX | Investor A | Mutual fund | 1.11% | 5.25% | 0.25% | +9.9% | +4.5% | +9.0% |
| SHSCX | Investor C | Mutual fund | 1.9% | 0% | 1% | +14.1% | +4.8% | +8.9% |
| SHISX | Service | Mutual fund | 1.16% | — | 0.25% | +15.9% | +5.5% | +9.5% |
| — | Class R Shares | Mutual fund | 1.47% | 0% | 0.5% | +15.6% | +5.2% | +9.2% |
| — | Class K | Mutual fund | 0.76% | — | 0% | +16.4% | +5.9% | +9.9% |
Source: Fund prospectus, filed Sep 25, 2026
Objective
The investment objective of BlackRock Health Sciences Opportunities Portfolio (the Fund), a series of BlackRock Funds SM (the Trust), is to provide long-term growth of capital.
Top holdings
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%